Managing editor of the Kaiser Daily Global Health Policy Report, Jill Braden Balderas, talks with global health leaders participating in AIDS 2010.

brightcove.createExperiences();

Family Health International President of Research Ward Cates, MD, MPH, and CONRAD Executive Director Henry Gablenick, PhD, discuss the CAPRISA trial results showing an antiretroviral-based microbicide reduced the risk of HIV infection in women by 39%.

brightcove.createExperiences();

Lydia Mungherera, MD, an HIV-positive physician from Uganda who represents African NGOs on the UNAIDS board, talks about what a viable microbicide would mean for women and what she thinks is key for donor nations helping Africa.

brightcove.createExperiences();

Vienna Notebook: Jon Cohen, a reporter for Science magazine, provides daily insights and observations from the conference in interviews with the Kaiser Family Foundation’s Jackie Judd.

All webcasts are available at http://www.kff.org/aids2010 .

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.